Mitochondria in cancer: at the crossroads of life and death

Fogg , Nathan , Lanning , Jeffrey
癌症:英文版 30 ( 8) 526 -539

172
2011
A Mitochondrial RNAi Screen Defines Cellular Bioenergetic Determinants and Identifies an Adenylate Kinase as a Key Regulator of ATP Levels

Nathan J. Lanning , Brendan D. Looyenga , Audra L. Kauffman , Natalie M. Niemi
Cell Reports 7 ( 3) 907 -917

44
2014
LRRK2 deficiency impairs trans-Golgi to lysosome trafficking and endocytic cargo degradation in human renal proximal tubule epithelial cells

Nathan J. Lanning , Calvin VanOpstall , Megan L. Goodall , Jeffrey P. MacKeigan
American Journal of Physiology-renal Physiology 315 ( 5)

8
2018
Downregulation of the mitochondrial phosphatase PTPMT1 is sufficient to promote cancer cell death.

Natalie M. Niemi , Nathan J. Lanning , Laura M. Westrate , Jeffrey P. MacKeigan
PLOS ONE 8 ( 1)

20
2013
Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

Nathan J. Lanning , Joshua P. Castle , Simar J. Singh , Andre N. Leon
Cancer and Metabolism 5 ( 1) 6 -6

64
2017
The Pseudophosphatase MK-STYX Physically and Genetically Interacts with the Mitochondrial Phosphatase PTPMT1

Natalie M. Niemi , Juliana L. Sacoman , Laura M. Westrate , L. Alex Gaither
PLoS ONE 9 ( 4) e93896

12
2014
DDK Promotes Tumor Chemoresistance and Survival via Multiple Pathways

Nanda Kumar Sasi , Arjun Bhutkar , Nathan J. Lanning , Jeffrey P. MacKeigan
Neoplasia 19 ( 5) 439 -450

9
2017
43
2008
Unique metabolic contexts sensitize cancer cells and discriminate between glycolytic tumor types

Jonathan A Chacon-Barahona , Jeffrey P MacKeigan , Nathan J Lanning
Cancers 15 ( 4) 1158 -1158

3
2023
MK-STYX, a Catalytically Inactive Phosphatase Regulating Mitochondrially Dependent Apoptosis

Natalie M Niemi , Nathan J Lanning , Jeff A Klomp , Stephen W Tait
Molecular and Cellular Biology 31 ( 7) 1357 -1368

27
2011
Phosphorylation of the adaptor protein SH2B1β regulates its ability to enhance growth hormone-dependent macrophage motility

Hsiao-Wen Su , Nathan J Lanning , David L Morris , Lawrence S Argetsinger
Journal of Cell Science 126 ( 8) 1733 -1743

26
2013
Recent advances in growth hormone signaling

Nathan J Lanning , Christin Carter-Su
Reviews in Endocrine and Metabolic Disorders 7 225 -235

288
2006
C/EBPβ mediates growth hormone-regulated expression of multiple target genes.

Tracy X. Cui , Grace Lin , Christopher R. LaPensee , Anda-Alexandra Calinescu
Molecular Endocrinology 25 ( 4) 681 -693

23
2011
Targeted disruption of Mig-6 in the mouse genome leads to early onset degenerative joint disease

Y.-W. Zhang , Y. Su , N. Lanning , P. J. Swiatek
Proceedings of the National Academy of Sciences of the United States of America 102 ( 33) 11740 -11745

82
2005
Identification of SH2B1β as a focal adhesion protein that regulates focal adhesion size and number

N. J. Lanning , H.-W. Su , L. S. Argetsinger , C. Carter-Su
Journal of Cell Science 124 ( 18) 3095 -3105

14
2011
Focus: Organelles: Phosphorylation of OXPHOS Machinery Subunits: Functional Implications in Cell Biology and Disease

Ernesto Castellanos , Nathan James Lanning ,
The Yale Journal of Biology and Medicine 92 ( 3) 523 -523

38
2019
Lung Adenocarcinoma Transcriptomic Analysis Predicts Adenylate Kinase Signatures Contributing to Tumor Progression and Negative Patient Prognosis

Jonathan A Chacon-Barahona , Ivan A Salladay-Perez , Nathan James Lanning ,
Metabolites 11 ( 12) 859 -859

3
2021